Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CKD-495 in Acute and Chronic Gastritis
NCT04255589Phase 3Completed
- Sponsor
- Chong Kun Dang Holdings
- Start
- Jan 2020
- Primary completion
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Artemisia argyi extract in acute gastritis, chronic gastritis, sponsored by Chong Kun Dang Holdings. Started Jan 2020; status: completed.
02
Drugs
Artemisia argyi extract
03
Conditions
acute gastritischronic gastritis
Beyond the preview
Go deeper on NCT04255589.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04255589.